Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aileen Chen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 9, 2014
Considerations for observational research using large data sets in radiation oncologyReshma Jagsi, Justin E Bekelman, Aileen Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
In reply to Rusthoven and KavanaghReshma Jagsi, Justin E Bekelman, Aileen Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2019
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLCAmy C Moreno, Bryan Fellman, Brian P Hobbs, et al.
Journal of Geriatric Oncology|September 25, 2017
Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapyIdalid Franco, Yu-Hui Chen, Fallon Chipidza, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2020
Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation TherapyZeina Ayoub, Matthew S Ning, Eric D Brooks, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2022
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancerTing Xu, Lirong Wu, Saumil Gandhi, et al.
JCO Oncology Practice|April 27, 2026
Yoga for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: Results of a Randomized Controlled TrialKathrin Milbury, Aileen Chen, Yisheng Li, et al.
Journal for Immunotherapy of Cancer|October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignanciesJoe Y Chang, Xinyan Xu, Girish S Shroff, et al.
BMJ Supportive & Palliative Care|March 2, 2026
Preoperative radiotherapy for appendicular bone metastases: outcomesJane B Pearce, Prasamsa Pandey, Comron Hassanzadeh, et al.
Clinical Lung Cancer|May 3, 2025
Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung CancerAbigael Odwuor, Percy Lee, Joe Y Chang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|September 9, 2014
Considerations for observational research using large data sets in radiation oncologyReshma Jagsi, Justin E Bekelman, Aileen Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
In reply to Rusthoven and KavanaghReshma Jagsi, Justin E Bekelman, Aileen Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2019
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLCAmy C Moreno, Bryan Fellman, Brian P Hobbs, et al.
Journal of Geriatric Oncology|September 25, 2017
Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapyIdalid Franco, Yu-Hui Chen, Fallon Chipidza, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2020
Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation TherapyZeina Ayoub, Matthew S Ning, Eric D Brooks, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2022
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancerTing Xu, Lirong Wu, Saumil Gandhi, et al.
JCO Oncology Practice|April 27, 2026
Yoga for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: Results of a Randomized Controlled TrialKathrin Milbury, Aileen Chen, Yisheng Li, et al.
Journal for Immunotherapy of Cancer|October 9, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignanciesJoe Y Chang, Xinyan Xu, Girish S Shroff, et al.
BMJ Supportive & Palliative Care|March 2, 2026
Preoperative radiotherapy for appendicular bone metastases: outcomesJane B Pearce, Prasamsa Pandey, Comron Hassanzadeh, et al.
Clinical Lung Cancer|May 3, 2025
Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung CancerAbigael Odwuor, Percy Lee, Joe Y Chang, et al.
Pageof 3